MedPath
NMPA Approval

Fosaprepitant Dimeglumine for Injection

国药准字H20213106

February 2, 2021

Drug Information

注射用福沙匹坦双葡甲胺

注射剂

0.15g(以C23H22F7N4O6P计)

化学药品

February 2, 2021

Company Information

Applicant Company

山东省济南市高新区新泺大街317号

Manufacturing Company

齐鲁制药有限公司;齐鲁制药(海南)有限公司

山东省济南市高新区旅游路8888号;海口市国家高新区南海大道273号-A

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用福沙匹坦双葡甲胺 - NMPA 批准文号 | MedPath